On Black Friday, online shoppers will be glued to their screens searching for the biggest

Facebook Marketplace is the most complained-about online retail platform for selling counterfeit, poor-quality and potentially unsafe goods, Trading Standards has reported. The online giant, which enables third-party sellers to trade goods on the platform via the marketplace, was criticised for being slow to take action against problem sellers and for enabling misleading product descriptions, counterfeit goods and potentially harmful products to reappear on its platform after being taken down. A national survey by the Chartered Trading Standards Institute (CTSI) found the online giant causes its officers the most concern, as well as being unresponsive or unco-operative when contacted about problem sellers. More than half (53 per cent) of respondents representing about 50 local authorities across the UK identified Facebook as the most complained-about online marketplace – more than all of the others combined. If it wants to be seen as a proper online retailer where people can buy safe and legitimate goods, it needs to start acting like one CTSI chief executive John Herriman The CTSI’s survey, the first of its kind, also found that Trading Standards teams were unable to properly address problems with online marketplaces because of a “triple whammy” of recurring issues – unco-perative businesses, unsuitable legislation and limited resources. Just 10 per cent of Trading Standards officers said they had been able to take action against online marketplaces as a result of these three obstacles. The CTSI’s survey found that 45 per cent of officers cited a lack of co-operation from online marketplaces as a recurring problem, 63 per cent said the law as it stands is not fit for purpose and 57 per cent had received no response when attempting to contact sellers on online marketplaces. Some 59 per cent said they had been unable to locate details about where third-party sellers on online marketplaces were based and 29 per cent said they wee unable to deal with complaints about online marketplaces because of a lack of time and resources. CTSI chief executive John Herriman said: “Facebook Marketplace needs to up its game. At a time when more and more people are going online to buy things, there is a real urgency for online retailers to take their responsibilities to their customers more seriously. Currently, online marketplaces like eBay and Facebook Marketplace are operating with fewer safety regulations than traditional high street retailers, eroding fair competition and allowing the sale of unsafe goods to flood the market unabated Martyn Allen, Electrical Safety First “The fact that Facebook Marketplace is an offshoot of a social media platform rather than a service that was built as an online retailer from the ground up speaks volumes. If it wants to be seen as a proper online retailer where people can buy safe and legitimate goods, it needs to start acting like one. “Failing to take action against sellers who use their platform to mislead, rip off and potentially endanger consumers just isn’t good enough. “We are calling for all online marketplaces to take action against problem sellers, for the law to be tightened up so enforcers have more tools at their disposal to protect consumers, and for more resources that enable us to do that more effectively.” A Meta spokesman said: “We take these issues seriously and when we find listings that violate our rules, we remove them. “We also work closely with external partners and respond to valid legal requests from law enforcement and the Office for Product Safety and Standards, to prevent illegal activity on our platforms.” Phil Lewis, director general of the Anti-Counterfeiting Group (ACG), said: “Criminals rely on legal e-commerce platforms, social media, maritime freight companies, express couriers, airlines, postal services and internet hosting services to set up rogue shopping sites. “ACG is calling on government to recognise the growing international threats to our families, job-providing businesses and the economy. “Appropriate enforcement resources and a policy architecture are desperately needed to ensure the companies providing these services work alongside our enforcement authorities and businesses, to combat this intensifying threat.” Martyn Allen, technical director of the charity Electrical Safety First, said: “Sadly, the high number of complaints Trading Standards officers receive regarding online purchases comes as no surprise. Online retailers like Facebook Marketplace need to be held to account just like any other type of business, otherwise consumers and legitimate businesses lose out Yvonne Fovargue, APPG on Consumer Protection “Currently, online marketplaces like eBay and Facebook Marketplace are operating with fewer safety regulations than traditional high street retailers, eroding fair competition and allowing the sale of unsafe goods to flood the market unabated. This puts UK citizens at serious risk of injury and harm. “It’s been a year and a half since the UK Government promised publication of the Product Safety Review, which is expected to include proposals to protect British consumers when they shop online. “The time for waiting is over – the Government must prioritise publishing the Review without any further delay.” Yvonne Fovargue, chairwoman of the All Party Parliamentary Group on Consumer Protection, said: “Since the pandemic and now, with the cost-of-living crisis, more people are buying products from online marketplaces. “These consumers deserve to be treated fairly and should be able to be confident that what they buy is safe and accurately described. “Online retailers like Facebook Marketplace need to be held to account just like any other type of business, otherwise consumers and legitimate businesses lose out.” Read More Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live UKRI announces £50 million to develop trustworthy and secure AI ‘Last Beatles record’ was created using AI, says Paul McCartney Put ‘public good’ at heart of AI and new tech, Starmer to say

Hailey Bieber has grand plans for her skin-care label, Rhode, aiming to stand out in an increasingly crowded

TL;DR: Unblock YouTube Premium from anywhere in the world with a VPN. ExpressVPN is the

A pack of dingoes has injured a woman who was jogging on a popular Austrailian tourist island in the latest clash between humans and native dogs

"Blueberry milk nails" are apparently the manicure style for summer. The so-called aesthetic has been

EU lawmakers on Tuesday backed proposals to boost journalistic independence, but stopped short of pushing for a blanket ban on...

TL;DR: Need a gift to wow someone special this holiday season without breaking the bank?

TL;DR: As of July 15, get this refurbished Microsoft Surface 3 laptop for just $425.99

A combative three-judge panel at one of the most conservative courts in the country grilled attorneys for the federal government and a drug manufacturer as anti-abortion activists continue a legal battle to overturn the government’s approval of a widely used abortion drug. On 17 May, the case against mifepristone returned to the Fifth Circuit Court of Appeals in New Orleans, where attorneys for the US Department of Justice and drug manufacturer Danco Laboratories faced skeptical Republican-appointed judges hearing oral arguments in a case that could upend abortion care for millions of Americans. Within seconds of her opening argument, Justice Department attorney Sarah Harrington was interrupted by Judge James Ho, a Donald Trump appointee, who challenged her description of the legal challenge against the drug’s approval by the US Food and Drug Administration. “I don’t think there’s ever been any court that has vacated an FDA determination that a drug is safe to be on the market,” she replied. “FDA can make that determination based on exercising its own scientific expertise, but it’s not a court’s role to come in and second-guess that expertise.” “Why not focus on the facts,” Judge Ho said, “rather than this ‘FDA can do no wrong’ theme.” The judges repeatedly interrupted Ms Harrington and appeared sympathetic to the plaintiffs: an anti-abortion group represented by influential right-wing legal group Alliance Defending Freedom, whose senior counsel Erin Morrow Halley – the wife of Republican senator Josh Hawley – baselessly asserted that medication abortion is “particularly dangerous”. Judge Jennifer Walker Elrod, who was appointed by George W Bush, also took a moment to chastise lawyers for their “unusual remarks” in filings objecting to the widely derided lower-court decision from a former right-wing activist attorney who was appointed to the federal bench by Mr Trump. Judge Elrod suggested their criticisms amounted to personal attacks and suggested that the attorney retract the statements and apologise. “Those statements reflect our view that the district court was very outside the bounds,” said Jessica Ellsworth, an attorney for Danco. “I don’t think those remarks, any of them, were intended as any personal attack.” The judges are not expected to rule immediately. But a decision from the panel judges – each with a history of support for abortion restrictions – is likely to return the case to the US Supreme Court, which has paused any action on mifepristone until the legal challenge plays out. In her arguments, Ms Hawley conflated the risk of serious complications from mifepristone – which is less than 1 per cent – with the risk that a medication abortion failed and would then require medical attention. Her arguments suggested that doctors are enduring a moral harm by providing abortion care, without evidence that doctors have been forced to do so, while also claiming that the FDA illegally approved the drug when it was approved more than 20 years ago. The judges repeatedly questioned the FDA’s approval process for mifepristone, which plaintiffs argued was done too hastily through an expedited process that is typically reserved for treating serious or life-threatening illnesses. But the FDA did not do that with mifepristone; it took years of study before the FDA’s approval. The part of that process that the agency invoked for mifepristone’s approval allowed the FDA to add safety restrictions, such as a requirement that physicians be able to diagnose ectopic pregnancies. But judges appeared to argue that because pregnancy is not an illness, mifepristone should not have been approved through that process at all, repeating plaintiffs’ false claim that the FDA called pregnancy a “life-threatening illness.” “When we celebrated Mothers’ Day, were we celebrating illness?” Judge Ho said at one point. “The arguments today demonstrated in detail that the case has no legal or scientific merit and should have been laughed out of court from the very start,” Jennifer Dalven, director of the ACLU Reproductive Freedom Project, said in a statement. “Unfortunately, the deck is stacked as the judges hearing this case are well known for their extraordinary hostility to abortion,” she added. “The whole point of the case is to prevent anyone in America, no matter where they live, from using a medication that has been safely used in this country for decades and is used in most abortions today.” Major medical groups and research from hundreds of studies over the last two decades have confirmed the overwhelming safety and efficacy of the drug, one of two drugs used in a two-drug protocol for a medication abortion, the most common form of abortion care in the US. Studies show it is as safe to use as common over-the-counter pain relievers like ibuprofen and acetaminophen, and the protocol for medication abortion is used in more than 60 other countries. The drug was first approved by the FDA in 2000 and is approved for use up to 10 weeks of pregnancy. A vast majority of abortions occur within the first nine weeks of pregnancy. From 2019 through 2020, nearly 93 per cent of all abortions were performed before the 13th week, according to the US Centers for Disease Control and Prevention. Mifepristone is also used to treat miscarriages. Roughly 10 per cent of clinically recognised pregnancies end in miscarriages, according to the American College of Obstetricians and Gynecologists. The American College of Obstetricians and Gynecologists and the American Medical Association also joined a brief in the challenge opposing arguments from anti-abortion groups. Last year, Alliance Defending Freedom filed a lawsuit in US District Court in Amarillo, Texas on behalf of a group of anti-abortion activists incorporated as the Alliance for Hippocratic Medicine, which was organised that same month with an address in Amarillo. The Alliance Defending Freedom also led the challenge at the Supreme Court that ultimately struck down Roe v Wade. In April, US District Judge Matthew Kacsmaryk – a former right-wing activist lawyer who was appointed to the federal judiciary by then-President Trump – issued a ruling to suspend the FDA’s approval of mifepristone, which was immediately challenged by abortion rights advocates, providers, major medical groups, drug manufacturers and the Biden administration. An appeal landed at the Fifth Circuit court, which has jurisdiction over the Amarillo court. A three-judge panel blocked a part of the judge’s ruling, and a subsequent ruling at the Supreme Court paused the lower-court ruling as the legal challenge continues. Read More North Carolina Republicans approve 12-week abortion ban as sweeping restrictions spread across US South Nebraska Republicans approve combined gender-affirming care ban and anti-abortion bill after epic filibuster Anti-abortion laws harm patients facing dangerous and life-threatening complications, report finds A Texas man sued his ex-wife’s friends for allegedly helping her with an abortion. Now they’re suing him Louisiana Republicans refuse rape and incest exceptions to state’s sweeping anti-abortion law What is mifepristone? The widely used pill in the abortion rights battle at the Supreme Court

TL;DR: As of August 12, you can get the 2023 Ultimate AI ChatGPT and Python

Welcome to the world post-Taylor Swift: The Eras Tour'. Swifties filled cinemas — and our